Daily non-political popular news in brief.

Delay in use of nevirapine-based AIDS treatment can improve outcomes

01-10-2007 · EurekAlert!

Delaying the use of nevirapine-containing antiretroviral therapy (ART) for at least six months after labor may improve treatment outcomes among HIV-infected women in developing countries who took nevirapine during labor to prevent their babies from becoming infected, suggests a new study in the New England Journal of Medicine. The study, led by a researcher at Harvard School of Public Health and Brigham and Women's Hospital, appears in the January 11, 2007, issue of the journal.

Keywords: delay, nevirapine-based, aids, treatment, improve, outcomes, nevirapine, based, aid, outcome

« Previous | Next »

Similar news on "Delay in use of nevirapine-based AIDS treatment can improve outcomes":

Mayo Clinic study indicates medication for ADHD may help student outcomes
09-18-2007 · EurekAlert!
In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
Similar news · Read more »
Lowering body temperature could aid standard stroke treatment
05-17-2007 · EurekAlert!
University of Cincinnati scientists have developed a model that could help physicians combine current clot-busting medication with below-normal body temperatures (hypothermia) to improve the treatment of ischemic stroke patients.
Similar news · Read more »
Improved imaging for identifying breast cancer in overweight women
02-06-2007 · EurekAlert!
Increasing the ability to identify sentinel nodes -- the very first lymph nodes that trap cancer cells draining away from a breast lesion site -- has a major impact in the treatment and outcome of breast cancer patients, possibly eliminating the need for unnecessary and painful surgery. Researchers found that using SPECT/CT imaging aids in sentinel node identification -- especially for overweight or obese women, according to a report in the February issue of the Journal of Nuclear Medicine.
Similar news · Read more »
Preclinical results of Geovax's AIDS vaccines demonstrate potential to protect against disease
02-06-2007 · EurekAlert!
GeoVax Labs, Inc., an Atlanta-based biotechnology company, today reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome ("AIDS") in non-human primates. The data demonstrate the effectiveness of GeoVax's DNA/MVA vaccines in controlling the Simian ("SIV") AIDS virus through immune responses raised by the vaccines. These promising results have resulted in preliminary plans to conduct human therapeutic studies utilizing GeoVax's vaccines.
Similar news · Read more »
Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
Similar news · Read more »
Research suggests new treatment suitable for all patients
01-01-2008 · EurekAlert!
New research at Wake Forest University Baptist Medical Center suggests that a three-drug cocktail may one day improve outcomes in patients with glioblastoma multiforme, a type of brain tumor with a dismal prognosis. Two of the drug candidates have been developed, and the team is working on the third -- all targeted to kill or impair cancer cells and spare healthy brain.
Similar news · Read more »
Radioactive 'understudy' may aid medical imaging, drug development
01-09-2008 · EurekAlert!
Broadway stars have understudies. Now, an increasingly popular radioactive isotope has its own stand-in. Developed in part by researchers at the National Institute of Standards and Technology, the substance might ultimately improve medical imaging, speed up clinical trials of many drugs and facilitate efforts to develop more individualized medical treatment.
Similar news · Read more »
Medication does not appear to improve symptoms or outcomes for patients with acute heart failure
11-06-2007 · EurekAlert!
The medication tezosentan, which was thought could be beneficial for the treatment of acute heart failure, did not improve breathlessness or reduce the risk of fatal or nonfatal cardiovascular events, according to a study in the Nov. 7 issue of JAMA.
Similar news · Read more »
Rounding up rodeo injuries aids prevention
07-13-2007 · EurekAlert!
This summer, University of Calgary sports epidemiologist Dale Butterwick -- a leader in the field of rodeo injury study and treatment -- is opening a registry for catastrophic injuries in pro rodeo to get a better idea of how frequently cowboys around the world are seriously hurt.It is the first such registry of its kind for professional rodeo and is based on similar injury registry systems in place for many elite sporting activities.
Similar news · Read more »
Potent peptides inhibit HIV entry into cells
10-10-2007 · EurekAlert!
Based in part on protein structures determined at the National Synchrotron Light Source at the US Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class. These peptides are sufficiently potent to begin preclinical studies as a new class of agents for the prevention and treatment of HIV/AIDS.
Similar news · Read more »